## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T
โฆ LIBER โฆ
Novel Targeted Therapies and Vaccination Strategies for Mesothelioma
โ Scribed by Mamta Bagia; Anna K. Nowak
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 180 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Novel targeted therapies in inflammatory
โ
Massimo Cristofanilli
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 84 KB
๐ 2 views
Trial Designs for Targeted Therapies
โ
Simon G. Thompson
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 44 KB
Molecularly targeted therapies for gliom
โ
Ryuya Yamanaka; Hideyuki Saya
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 538 KB
Current therapies for malignant pleural
โ
Takashi Nakano
๐
Article
๐
2008
๐
Japan Science and Technology Information Aggregato
๐
English
โ 266 KB
Strategies for optimizing targeting and
โ
Jeffrey D. Ahlers; Igor M. Belyakov
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 246 KB
๐ 1 views
Cholangiocarcinoma: Molecular targeting
โ
Alphonse E. Sirica
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 306 KB
๐ 1 views
Cholangiocarcinomas are devastating cancers that are increasing in both their worldwide incidence and mortality rates. The challenges posed by these often lethal biliary tract cancers are daunting, with conventional treatment options being limited and the only hope for long-term survival being that